As a group, the general health of patients with end stage renal disease (ESRD) remains poor, even after more than 30 years of experience in providing treatment for them. In the United States the expected remaining life expectancy for middle aged adults starting dialysis is only 23% of the overall population; and more than 25% of patients with ESRD die during the first year of treatment (1) . Cardiac and other vascular disease account for 48% of deaths. Intermittent hypokalemia associated with dialysis treatments and excessive dietary potassium restrictions could possibly contribute to the high incidence of cardiovascular disease in the ESRD population (2) . Although various nutritional factors have been associated with mortality in dialysis patients, the relation between potassium balance and cardiovascular health has not been extensively investigated (3, 4) . Individuals with normal renal function, however, show cardiovascular benefits from consuming a potassium-rich diet. Potassium, the major intracellular cation, has an important role in the function of mammalian cells. Epidemiological studies have shown that potassium consumption correlates inversely with the incidence of hypertension; and the use of large doses of potassium wasting diuretics to control blood pressure might increase the incidence of fatal arrhythmias (5) . Accordingly, restriction of dietary potassium and acute loses during hemodialysis could contribute to the cardiovascular mortality of ESRD patients.
Hemodialysis patients are prescribed low potassium diets. In persons with normal kidney function, a potassium deficient diet is associated with higher blood pressures and an increased risk for myocardial infarction, heart failure, and stroke (6) (7) (8) . Data taken from the Health and Nutrition Examination Survey (HANES I) show an inverse relationship between potassium consumption and hypertension (9) . The incidence of vascular complications usually attributed to hypertension, particularly cerebral vascular accidents, are reduced in populations known to have an increased potassium intake. An effect of dietary potassium on the architecture of the vascular system independent of blood pressure has been demonstrated. Clinical studies revealed that Japanese farmers consuming a higher than average amount of potassium had fewer strokes than their 0391-3988/134-02 $01.00/0 neighbours, without a difference in blood pressure between the two groups (10) . Effects of potassium on arterial vessels independent of blood pressure have also been observed in animals. Hypertensive Dahl rats fed a potassium-rich diet had less vascular hypertrophy than those consuming a potassium depleted diet, without a difference in blood pressure between the two groups (11) . Overall, diets rich in potassium appear to confer cardiovascular benefits. Hemodialysis patients, however, are typically given a low potassium diet, even if they are potassium depleted when ESRD is diagnosed.
Before dialysis is begun, patients with chronic renal failure are likely to have intracellular and total body K+ depletion (12) . Instituting dialysis resulted in an increase in total body potassium and normalization of K+ stores as the anorexia of uremia was relieved (13) . Dialysis, however removes potassium from patients and normalization of total body K+ requires that its intake exceed removal, at least initially. It is therefore possible that severely debilitated patients, or those with inadequate social support systems, may remain malnourished after dialysis is instituted, preventing normalization of their potassium stores. Indeed, using 4°K scintigraphic total body potassium measurement techniques, debilitated elderly patients with persistently inadequate nutrition had total body potassium values 20% below normalone year after starting dialysis (unpublished observation by author). This indicates that inadequate intake and excessive removal of potassium might prolong the depleted state.
Hemodialysis treatments remove potassium and acutely lower serum [K+] . Excessive potassium losses in hypertensive patients with normal renal function have adverse cardiac effects. Treatment of hypertension with potassium wasting diuretics did not lower the incidence of myocardial infarction to the same degree as stroke in two major studies, possibly due to an increase in cardiac arrhythmias in the potassium losing patients (14, 15) . In addition to possiblyincreasing arrhythmias, hypokalemia alters vascular contractility. The effects of dialysate potassium concentration on blood pressure have been determined in hemodialysis patients (2) . When dialysate potassium concentrations were 1.0 mmol/L, mean blood pressure one hour post dialysis (after the acute effects of volume removal had subsided) was greater than the pre-dialysis value. With dialysate potassium levels of 3.0 mmol/L, by contrast, blood pressure did not rise post treatment, nor was there hyperkalemia, then the post-dialysis serum [K+] did not fall below 4.0 mmol/L. Dialysate potassium concentrations of 1.0 mmol/I, however, lowered serum potassium to 3.5 mmol/L immediately post treatment. Therefore, excessive potassium removal by dialysis raises blood pressure, at least temporarily, and might affect the long term health of the patient should blood pressure remain elevatedbetween treatments.
In summary, hypertension and associated cardiovascular diseases are major causes of mortality in ESRD patients. Potassium poor diets and hypokalemia increase the incidence of hypertension and associated adverse cardiovascular consequences. Our efforts to restrict the intake of potassium and remove it by dialysis might worsen blood pressure control and increase the incidence of myocardial infarction, stroke, and cardiac arrhythmias. It would therefore seem reasonable to modify the dietary and dialysis prescription with regard to potassium. Liberalizing the dietary potassium restriction from 2 to 4 grams per day, for example, would make the renal diet more palatable and allow for an increase in the consumption of fruits and vegetables. For hemodialysis patients, increa-sing dialysate [K+] from 2.0 mmol/L to 3.0 mmol/L would limit the fall in serum [K+] during treatment and help prevent total body potassium depletion, especially in patients who are malnourished or have poor appetite. Increased attention to potassium balance, with efforts to prevent hypokalemia and total body potassium depletion, could benefit patients with ESRD by decreasing their significant mortality due to hypertension and cardiovascular diseases.
